版本:
中国

BRIEF-Ipsen announces Health Canada approval of dysport therapeutic for treatment of patients with cervical dystonia

March 14 Ipsen Sa

* Ipsen announces health canada approval of dysport therapeutic™ (abobotulinumtoxina) for the treatment of patients with cervical dystonia and adult upper limb spasticity Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐